Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis
- PMID: 30274977
- PMCID: PMC6709846
- DOI: 10.1373/clinchem.2018.287094
Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis
Conflict of interest statement
Conflict of interest
Andrew J. Vickers is named on a patent for a statistical method to detect prostate cancer. The test has been commercialized as 4Kscore® by OPKO Health. AV receives royalties from sales of the test. AV has stock options in OPKO Health, and participates on their Advisory Board.
References
-
- US Preventative Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, et al. Screening for prostate cancer: Us preventive services task force recommendation statement. Jama 2018;319:1901–13. - PubMed
-
- Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ, Eggener SE. National trends in prostate cancer screening among older american men with limited 9-year life expectancies: Evidence of an increased need for shared decision making. Cancer 2014;120:1491–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical